OR
ORGNW
Origin Materials, Inc.
$0.003200
0.00%
$1.1K
No data for this timeframe.
Vol
Market Cap$1.1K
Cap SizeNano Cap
Inst. Holders7 funds
Inst. Value$839.00
Inst. Activity0 buys / 2 sells
SEC Reports1
Recent Activity
May 1, 2026
SEC
Origin Materials announced a plan of complete liquidation and dissolution, subject to stockholder approval, and implemen
8-K — Impact 9/10
Inst.
WOLVERINE ASSET MANAGEMENT LLC — TRIM
3,561 shares ($179.00)
Inst.
UBS Group AG — TRIM
1,451 shares ($73.00)
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| ROYAL BANK OF CANADA | — | — |
| DEUTSCHE BANK AG\ | — | — |
| LMR Partners LLP | $502.00 | — |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $131.00 | — |
| TORONTO DOMINION BANK | $101.00 | — |
7 institutional holders with $839.00 total value (414,965 shares) as of 2026-Q1. Top holders: ROYAL, DEUTSCHE, LMR.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | ROYAL BANK OF CANADA | 500 | $0.00 | 0.0% | — |
| 2 | DEUTSCHE BANK AG\ | 75,000 | $0.00 | 0.0% | — |
| 3 | LMR Partners LLP | 200,977 | $502.00 | 59.8% | — |
| 4 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 54,427 | $131.00 | 15.6% | — |
| 5 | TORONTO DOMINION BANK | 50,500 | $101.00 | 12.0% | — |
| 6 | Marex Group plc | 30,000 | $96.00 | 11.4% | — |
| 7 | WOLVERINE ASSET MANAGEMENT LLC | 3,561 | $9.00 | 1.1% | TRIM -44.9% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| WOLVERINE ASSET MANAGEMENT LLC | TRIM | 6,461 | 3,561 | -44.9% | $179.00 | 2025-Q1 |
| UBS Group AG | TRIM | 2,473 | 1,451 | -41.3% | $73.00 | 2025-Q1 |
| WOLVERINE ASSET MANAGEMENT LLC | TRIM | 11,764 | 6,461 | -45.1% | $831.00 | 2024-Q4 |
| WOLVERINE ASSET MANAGEMENT LLC | ADD | 6,580 | 11,764 | +78.8% | $1.4K | 2024-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
1 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 0 neutral. Avg impact: 9.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.